Bank of Montreal’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,467
Closed -$404K 3828
2024
Q2
$404K Buy
+2,467
New +$351K ﹤0.01% 2539
2023
Q3
Sell
-7,377
Closed -$3.84M 3774
2023
Q2
$3.84M Sell
7,377
-400
-5% -$225K ﹤0.01% 1464
2023
Q1
$4.62M Sell
7,777
-3,623
-32% -$2.03M ﹤0.01% 1274
2022
Q4
$4.6M Buy
11,400
+3,860
+51% +$1.81M ﹤0.01% 1335
2022
Q3
$4.58K Sell
7,540
-1,734
-19% -$1.04M ﹤0.01% 1395
2022
Q2
$5.13K Sell
9,274
-496
-5% -$251K ﹤0.01% 1419
2022
Q1
$6.07M Buy
9,770
+2,318
+31% +$1.19M ﹤0.01% 1391
2021
Q4
$5.09M Sell
7,452
-715
-9% -$435K ﹤0.01% 1213
2021
Q3
$5.37M Buy
+8,167
New +$6.98M ﹤0.01% 1597

Other funds holding AGL

Bank of Montreal's AGL Position: Q3 2024 in Review

Bank of Montreal sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 2,467 shares — an estimated $404K sold.

Bank of Montreal first reported a position in AGL in Q3 2021 and held it in 9 quarters. The position peaked at $6.07M in Q1 2022. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Bank of Montreal reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 2,467 Agilon Health shares in Q3 2024, an estimated $404K.
  • Bank of Montreal first reported a position in Agilon Health in Q3 2021 and held it in 9 quarters.
  • Bank of Montreal's Agilon Health position peaked at $6.07M in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.